Topic resource collection
Approved comparison material connected to this topic.
479 resourcesRead both sides
TB-500 (Thymosin Beta-4) Upregulates actin to promote cell migration and tissue repair; reduces fibrosis 10–14 days for measurable effect; peak benefit at 4–6 weeks 2–5mg subcutaneous, twice weekly for 4–6 weeks Muscle strains, s…
Each peptide targets different aspects of the inflammatory and repair cascade. Here's how they compare in practical application. BPC-157 VEGF pathway activation, angiogenesis promotion in hypoxic tissue 250–500 mcg/day Once or tw…
CJC-1295/Ipamorelin GHRH + GHRP synergy for pulsatile GH release 100mcg each, 1–2× daily Preserves insulin sensitivity while activating lipolysis and anabolism simultaneously Requires injection; effects dependent on natural GH re…
Each peptide's efficacy depends on the injury type, inflammation phase, and tissue involved. Here's how the evidence breaks down across different joint pathologies. BPC-157 VEGF upregulation, angiogenesis at injury sites Acute te…
GHK-Cu vs BPC-157 compared: mechanisms, evidence, dosage, and when to use each. One has human clinical data, the other has broader preclinical reach.
BPC-157 vs TB-500 compared head-to-head: mechanisms, dosage, efficacy, side effects, and when to use each. Plus: the Wolverine Stack protocol.
Selank vs Semax compared head-to-head: mechanisms, dosage, effects, and when to use each. Both developed at Russia's Institute of Molecular Genetics.
Two distinct peptide categories serve different functions in combat sports protocols. Growth hormone secretagogues (GHRP-2, GHRP-6, Ipamorelin, MK-677) stimulate the pituitary gland to release endogenous GH in pulsatile waves. Mi…
MOTS-C Activates AMPK → mitochondrial biogenesis and substrate utilisation 5–10mg twice weekly subcutaneous 4–6 weeks (mitochondrial density) Best choice for athletes prioritising oxidative capacity over short-term recovery TB-50…
BPC-157 VEGF upregulation, angiogenesis induction Soft tissue repair (tendons, ligaments, muscle strains) 250–500 mcg daily, subcutaneous injection near injury site Subcutaneous Most reproducible evidence for accelerated tendon h…
CJC-1295/Ipamorelin Stimulates pulsatile GH secretion; improves lipolysis and lean mass retention 200–300mcg each, 3–5×/week subcutaneous Body composition changes visible at 8–12 weeks; metabolic markers improve at 4–6 weeks Mode…
BPC-157 VEGF upregulation, angiogenesis promotion 250–500mcg daily subcutaneous 7–14 days for tissue repair effects Tendon/ligament injuries, joint pain, gut inflammation Gold standard for injury recovery in research settings. Me…
Before selecting a peptide for PCOS research, match the mechanism to your model's primary phenotype. Insulin resistance, inflammation, or combined metabolic-reproductive dysregulation. Each peptide addresses different pathways, a…
GLP-1 Agonists (Semaglutide, Tirzepatide) Delays gastric emptying, reduces ghrelin rebound, improves insulin sensitivity 0.25mg-2.4mg weekly (titrated over 16-20 weeks) Appetite suppression in 3-7 days; measurable fat loss by wee…
BPC-157 VEGF upregulation, collagen synthesis Tendon repair, chronic injury recovery 250–500 mcg SubQ 1–2x daily Animal models + anecdotal (no human RCTs) Strong mechanistic basis; most reliable for localized soft tissue healing …
Before selecting peptides, understand the distinct role each category plays in supporting strength development. Growth Hormone Secretagogues (GHRP-2, GHRP-6, Ipamorelin, MK-677) Stimulate pituitary GH release via ghrelin receptor…
MOTS-C Mitochondrial-derived peptide, activates AMPK, regulates nuclear gene expression for metabolic flexibility Mitochondrial dysfunction, insulin resistance, declining exercise capacity 5–10mg, 2–3×/week Subcutaneous or intran…
Before selecting a peptide protocol, compare mechanisms, administration logistics, and clinical endpoints relevant to postmenopausal physiology. BPC-157 VEGF upregulation, collagen synthesis Daily subcutaneous (250–500mcg) 18% in…
CJC-1295 (with DAC) GHRH receptor agonist. Sustained GH pulse elevation Once weekly Restores anabolic signaling, supports lean mass retention, improves sleep quality 2–8°C after reconstitution, use within 28 days Best single pept…
GHRP-2 Ghrelin receptor agonist. Stimulates pulsatile GH release from pituitary 100mcg doses showed 35-50% IGF-1 increase in men 40-60 (clinical trial data) 100-300mcg subcutaneous 2-3x daily, pre-meal or pre-sleep GH pulse withi…